GL logo

Globe Life

GL · What the business does, what can go wrong, and how options sellers approach it

What it does

Globe Life is an insurance holding company. Its subsidiaries sell life insurance and supplemental health insurance, mainly to middle-income households. Supplemental health products are policies that pay out in specific situations, such as an accident or a cancer diagnosis, and are meant to work alongside major medical coverage.

Its main businesses are life insurance, supplemental health insurance, and the investment portfolio that supports them.

How it makes money

Customers pay premiums, and the company pays claims and benefits when covered events happen. It earns money when premiums and investment returns exceed claims, policy benefits, and the costs of selling and running the business.

The investment segment manages the premiums the company collects before claims are paid. Those assets are mostly fixed maturities (bonds), chosen to match the long-term obligations of the policies. Expected investment yields are considered when pricing policies.

Why investors own it

  • A business built on long-lived policies, which can produce recurring premium income.
  • A focus on specific niches rather than the broadest insurance market.
  • A history of returning capital to shareholders through dividends and share repurchases, though neither is guaranteed.
  • Profit is tied to underwriting discipline and cost control, not just market swings.

What can go wrong

  • Claims may exceed what the company priced for.
  • Early lapses hurt profitability, since selling a policy costs money up front.
  • Falling rates can cut investment income, and bond credit problems can cause losses.
  • Sales practices can draw regulatory scrutiny, and negative news can hurt the stock.
  • Short-seller reports or accounting disputes can quickly shift sentiment.

What to watch

  • Premium growth in life and supplemental health
  • Policy persistency (how many policies stay in force)
  • Underwriting margins and the benefit ratio
  • New sales trends and agent recruiting and retention
  • Portfolio credit quality and net investment yield
  • Regulatory or legal developments
  • Capital deployment: buybacks and dividends

Options income angle

GL options trade across several expirations but usually less actively than options on the most heavily traded stocks. Bid-ask spreads can be wider, especially on strikes far from the current price.

Implied volatility tends to rise around earnings and on news about claims, sales practices, regulation, or accounting. Rate and credit market swings can also move it.

One caution for premium sellers: insurance stocks can drop sharply in a single day on negative headlines. A short put or covered call position can be hit hard by an unexpected gap move.

What the latest 10-K says

A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended December 31, 2025, filed February 25, 2026. Figures are as the filing reports them. Read the filing on SEC.gov

The filing in brief

Globe Life reported net income of $1.16 billion for 2025, up from $1.07 billion in 2024. Life insurance profit margins improved, and a one-time benefit from the annual review of reserve assumptions helped. The filing also stresses ongoing short-seller litigation, a federal agency's view that some agents are employees, and the parent company's reliance on dividends from its insurance subsidiaries.

How the business did

  • Profit: Diluted net income per share was $14.07, compared with $11.94 in 2024. Net operating income, a non-GAAP measure that strips out realized investment gains and losses and unusual items, was $1.20 billion.
  • Premiums: Total premium rose 5% to $4.9 billion. Life premium grew 3% to $3.4 billion and health premium grew 9% to $1.5 billion. Life underwriting margin (premium less policy obligations, acquisition costs and commissions) was 45% of premium, up from 41%. A remeasurement gain of $130.9 million from updated reserve assumptions contributed. Excluding that, the margin was 41% against 40%.
  • Health: Health net sales rose 36% to $333 million, with United American net sales up 92% as Medicare Supplement demand grew. Health margin slipped to 26% of premium from 27% on higher claims.
  • Investments: Excess investment income (net investment income minus interest owed on policy reserves) fell 16% to $138 million from $164 million.
  • Cash and capital return: Operations produced $1.40 billion of cash in 2025 and 2024. The company repurchased 5.4 million shares for $685 million.

Risks specific to this company

  • Short-seller fallout: Short-seller reports in April 2024 hurt the stock and led to one putative securities class action and five shareholder derivative lawsuits. The company says it will defend them vigorously, but a judgment could materially affect results.
  • Agent classification: A significant portion of sales agents are independent contractors. In September 2024 the EEOC determined that all agents affiliated with State General Agent Simon Arias were employees. The finding is not binding, but any civil action would likely include that claim. Reclassifying agents could significantly raise costs.
  • Dependence on subsidiary dividends: The parent has no direct operations and relies on dividends from insurance subsidiaries, which state and Bermuda rules limit. Approximately $1.2 billion of life statutory reserves are ceded to GL Re under a 2025 intercompany agreement. Regulatory changes could require the parent to add capital.
  • Medicare Supplement pricing: This product has lower margins and needs annual rate increases that state regulators must approve. Delays would hurt profitability.
  • Investment risk: The portfolio is mostly long-term fixed maturities, and rising rates or credit spreads can create large unrealized losses. The filing also notes growing alternative investments, such as limited partnerships, that may be illiquid and volatile.
  • FHLB funding: The company relies on Federal Home Loan Bank funding for liquidity. Changes to collateral rules or to insurers' eligibility could force it to find replacement funding.

What management is watching

  • Agent growth: Agent count is described as the primary driver of future sales in exclusive agencies. Average producing agents were 11,920 at American Income, 3,846 at Liberty National and 1,527 at Family Heritage.
  • Parent cash for 2026: Dividends from subsidiaries and excess cash flows are projected to be lower than in 2025. 2025 included nonrecurring extraordinary dividends of $192 million in late 2024 and $80 million in 2025. The 2026 quarterly dividend is projected at $0.3300, versus $0.2700 in 2025.
  • Buybacks and capital: If market conditions are favorable, management expects share repurchases to remain a primary use of excess cash, with slightly more than $1.1 billion left under the authorization. It targets a consolidated Company Action Level RBC ratio (a regulatory capital measure) of 300% to 320%, and reported 316% for 2025.
  • Technology: Spending on sales technology such as CRM tools, and on underwriting technology at Direct to Consumer, is cited as supporting recruiting and sales conversion.
  • Measures management points to: Underwriting margin, excess investment income, net sales, first-year collected premium and net operating return on equity excluding AOCI (accumulated other comprehensive income), which was 16.0%.

What the latest 10-Q says

A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed November 4, 2026. Figures are as the filing reports them. Read the filing on SEC.gov

The quarter in brief

For the nine months ended September 30, 2026, Globe Life reported net income of $919 million, up 3% from $895 million, with total premium up 6% and health insurance growing fastest. Life underwriting profit was nearly flat because the annual assumptions review gave a smaller gain than a year earlier. In health, rapid Medicare Supplement growth came with thinner margins at United American, partly because of losses at its group health unit, Evry Health.

How the business did

  • Profit: Net operating income, the company's preferred measure that excludes items such as realized investment gains and losses, was $937 million versus $925 million, up 1%. Per diluted share it rose 7% to $11.86 from $11.13. Net income per diluted share rose 8% to $11.64 from $10.77.
  • Assumptions review: The third-quarter annual review of lapse, mortality and morbidity (illness) assumptions produced a $120.5 million net remeasurement gain, compared with $134.3 million in the year-ago quarter.
  • Life: Premium rose 3% to $2.58 billion. Underwriting margin (premium less policy costs and acquisition costs) was $1.17 billion versus $1.16 billion.
  • Health: Premium rose 15% to $1.30 billion, and underwriting margin rose to $309 million from $291 million. Medicare Supplement premium was $615 million, or 47% of health premium. Margin as a share of premium fell to 24% from 26%.
  • Cash and capital: Operating cash inflows were $1.06 billion versus $1.05 billion. The company repurchased 3.6 million shares for a total of $564 million. The quarterly dividend was raised 22% to $0.33 per share from $0.27.

What management is watching

  • Agent counts: American Income's average producing agent count fell 6% to 11,262 from 11,994 on lower retention of new agents, and middle management compensation was adjusted in response. Liberty National's count rose 9% to 4,137 and Family Heritage's rose 6% to 1,578.
  • Direct to Consumer and Evry: Direct to Consumer net sales fell 7% to $78 million as AI use in consumer search cut paid search volume, though inquiry rates improved this quarter. For Evry, which had an underwriting loss of $26 million, management is working on pricing, underwriting discipline and selective growth, and warns of continued volatility.
  • Capital use: On August 5, 2026 the board authorized up to $2.5 billion for share repurchases, with $2.4 billion remaining at September 30, 2026. If market conditions are favorable, management expects repurchases to remain a primary use of excess cash.
  • Measures cited: Management points to underwriting margin, excess investment income, net sales and first-year collected premium. It also cites net operating return on equity excluding accumulated other comprehensive income (AOCI, mainly interest-rate-driven value changes in bond holdings), which was 15.9% for the nine months.

Follow GL in Kortex

The Kortex app shows GL's price, options chain and IV rank, and answers your questions from live market data and SEC filings.

Free to download.

Learn the strategies

More stock briefs

For education only, not financial advice. Options involve risk and are not suitable for every investor.